Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-18

Clinical Trial Update: Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effects of combining donepezil and selegiline on cocaine-reinforced behavior in cocaine use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil (donepezil)
  • Selegiline (selegiline)

Snippet

Sponsor: Midwest Biomedical Research Foundation | Conditions: Cocaine Use Disorders | Phase 2 | Status: COMPLETED